Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,totalCashflowsFromInvestingActivities,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,epsTrailingTwelveMonths,currency,priceHint,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,exchange,exchangeDataDelayedBy,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,shortName,market,marketState,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Oct 30, 2016) 4","Short Ratio (Oct 30, 2016) 4","Short % of Float (Oct 30, 2016) 4","Short % of Shares Outstanding (Oct 30, 2016) 4","Shares Short (prior month Sep 29, 2016) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry,address2
t0,ESMC,524105,7415330,215700,,-137465,,-137465,858165,941640,-132225,-132225,,-5398,,,,0,2324907,2457132,1383267,-5240,,-137465,-150188,107312,69702043,4300370,631417,629211,5576787,7415,406580,-69078041,40860,62789,1653087,3354608,450127,999732,4406954,973476,212053,1373811,954989,81978.0,-927.0,-927.0,-38796.0,122210.0,123137.0,10776.0,-42236.0,190405.0,58475.0,,,1052346,en-US,US,EQUITY,False,Delayed Quote,0.0,0.1511 - 0.1511,0.1511,0.0,0.0,0,0,finmb_28223,Other OTC,Escalon Medical Corp.,USD,4746,4983,0.0711,0.88874996,0.08 - 0.55,-0.39890003,-0.7252728,0.08,0.55,-0.101,USD,4,0.104,0.17833333,-0.027233332,-0.15271027,0.26630434,-0.11520435,-0.4326041,1120456,1.4528846,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.1511,1630346949,0.0,0.19546,0.1511,0.1511,23200,ESCALON MEDICAL CORP,us_market,REGULAR,-0.64,,,0.55,0.08,0.1783,0.2663,4.75k,4.98k,7.42M,,7.27M,1.90%,0.00%,2.01k,0.31,0.03%,0.03%,2.13k,,,,,,0.00%,,,1:4,"Nov 23, 1997","Jun 29, 2020","Mar 30, 2021",-7.29%,-7.09%,-7.69%,-43.23%,9.65M,1.30,-1.40%,4.2M,-638.87k,-755.39k,-0.1010,,1.65M,0.22,1.84M,144.34,1.31,0.10,341.94k,534.58k,Value,19087,Healthcare,38,"Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and pachymeter that measures the thickness of cornea. The company also provides color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; distributes intraocular gas products, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and manufactures and distributes a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it offers disposable surgical packs that are used in vitreoretinal surgery; viscous fluid transfer systems and related disposable syringe products, which aid surgeons in the process of injecting and extracting silicone oil; and AXIS Image management system for managing images through the Web browser from various devices regardless of modality, manufacturer, or location. The company sells its products to medical institutions through independent sales representatives, a network of distributors, and internal sales employees. Escalon Medical Corp. was founded in 1987 and is headquartered in Wayne, Pennsylvania.",Wayne,610 688 6830,PA,1609372800,United States,http://www.escalonmedical.com,86400,435 Devon Park Drive,610 688 3641,Medical Devices,Suite 824
t-1,ESMC,656657,7415330,244529,,98476,,98476,883987,1232268,103752,103752,,-5469,,,,0,2898088,2794336,1665820,-5276,,98476,85470,112225,69702043,4295285,768882,710198,5709167,7415,437511,-68940576,40861,62789,1531033,3109185,282462,1070153,4464000,1163881,380645,1331575,796383,-19618.0,-908.0,-908.0,-119586.0,165272.0,175570.0,10851.0,253386.0,-118344.0,70405.0,-9390.0,-9390.0,1354815,en-US,US,EQUITY,False,Delayed Quote,0.0,0.1511 - 0.1511,0.1511,0.0,0.0,0,0,finmb_28223,Other OTC,Escalon Medical Corp.,USD,4746,4983,0.0711,0.88874996,0.08 - 0.55,-0.39890003,-0.7252728,0.08,0.55,-0.101,USD,4,0.104,0.17833333,-0.027233332,-0.15271027,0.26630434,-0.11520435,-0.4326041,1120456,1.4528846,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.1511,1630346949,0.0,0.19546,0.1511,0.1511,23200,ESCALON MEDICAL CORP,us_market,REGULAR,-0.64,,,0.55,0.08,0.1783,0.2663,4.75k,4.98k,7.42M,,7.27M,1.90%,0.00%,2.01k,0.31,0.03%,0.03%,2.13k,,,,,,0.00%,,,1:4,"Nov 23, 1997","Jun 29, 2020","Mar 30, 2021",-7.29%,-7.09%,-7.69%,-43.23%,9.65M,1.30,-1.40%,4.2M,-638.87k,-755.39k,-0.1010,,1.65M,0.22,1.84M,144.34,1.31,0.10,341.94k,534.58k,Value,19087,Healthcare,38,"Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and pachymeter that measures the thickness of cornea. The company also provides color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; distributes intraocular gas products, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and manufactures and distributes a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it offers disposable surgical packs that are used in vitreoretinal surgery; viscous fluid transfer systems and related disposable syringe products, which aid surgeons in the process of injecting and extracting silicone oil; and AXIS Image management system for managing images through the Web browser from various devices regardless of modality, manufacturer, or location. The company sells its products to medical institutions through independent sales representatives, a network of distributors, and internal sales employees. Escalon Medical Corp. was founded in 1987 and is headquartered in Wayne, Pennsylvania.",Wayne,610 688 6830,PA,1609372800,United States,http://www.escalonmedical.com,86400,435 Devon Park Drive,610 688 3641,Medical Devices,Suite 824
t-2,ESMC,553269,7415330,209322,,-196553,,-196553,892177,909925,-191574,-191574,,-5518,,,,0,2413794,2605368,1503869,-4979,,-196553,-209523,117137,69702043,4427759,670406,561154,5743165,7415,434295,-69039052,44736,62792,1365954,3190997,309097,1132489,4430747,1045537,354918,1584961,919567,110393.0,-889.0,-889.0,70495.0,540190.0,541079.0,11303.0,200069.0,267398.0,77974.0,-9390.0,-9390.0,1239750,en-US,US,EQUITY,False,Delayed Quote,0.0,0.1511 - 0.1511,0.1511,0.0,0.0,0,0,finmb_28223,Other OTC,Escalon Medical Corp.,USD,4746,4983,0.0711,0.88874996,0.08 - 0.55,-0.39890003,-0.7252728,0.08,0.55,-0.101,USD,4,0.104,0.17833333,-0.027233332,-0.15271027,0.26630434,-0.11520435,-0.4326041,1120456,1.4528846,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.1511,1630346949,0.0,0.19546,0.1511,0.1511,23200,ESCALON MEDICAL CORP,us_market,REGULAR,-0.64,,,0.55,0.08,0.1783,0.2663,4.75k,4.98k,7.42M,,7.27M,1.90%,0.00%,2.01k,0.31,0.03%,0.03%,2.13k,,,,,,0.00%,,,1:4,"Nov 23, 1997","Jun 29, 2020","Mar 30, 2021",-7.29%,-7.09%,-7.69%,-43.23%,9.65M,1.30,-1.40%,4.2M,-638.87k,-755.39k,-0.1010,,1.65M,0.22,1.84M,144.34,1.31,0.10,341.94k,534.58k,Value,19087,Healthcare,38,"Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and pachymeter that measures the thickness of cornea. The company also provides color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; distributes intraocular gas products, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and manufactures and distributes a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it offers disposable surgical packs that are used in vitreoretinal surgery; viscous fluid transfer systems and related disposable syringe products, which aid surgeons in the process of injecting and extracting silicone oil; and AXIS Image management system for managing images through the Web browser from various devices regardless of modality, manufacturer, or location. The company sells its products to medical institutions through independent sales representatives, a network of distributors, and internal sales employees. Escalon Medical Corp. was founded in 1987 and is headquartered in Wayne, Pennsylvania.",Wayne,610 688 6830,PA,1609372800,United States,http://www.escalonmedical.com,86400,435 Devon Park Drive,610 688 3641,Medical Devices,Suite 824
t-3,ESMC,744909,7415330,313898,,-468427,,-468427,877475,726745,-464628,-464628,,-3799,,,,0,2014767,2479395,1288022,-3799,,-468427,-481150,122050,69702043,4210618,866959,652441,5722577,7415,409474,-68842499,8872,62789,825958,2865007,224698,1204341,4333397,1312935,440206,1785030,760621,52728.0,649129.0,649129.0,-112075.0,130499.0,-497850.0,12878.0,115238.0,-210906.0,112714.0,-20780.0,-20780.0,1468390,en-US,US,EQUITY,False,Delayed Quote,0.0,0.1511 - 0.1511,0.1511,0.0,0.0,0,0,finmb_28223,Other OTC,Escalon Medical Corp.,USD,4746,4983,0.0711,0.88874996,0.08 - 0.55,-0.39890003,-0.7252728,0.08,0.55,-0.101,USD,4,0.104,0.17833333,-0.027233332,-0.15271027,0.26630434,-0.11520435,-0.4326041,1120456,1.4528846,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.1511,1630346949,0.0,0.19546,0.1511,0.1511,23200,ESCALON MEDICAL CORP,us_market,REGULAR,-0.64,,,0.55,0.08,0.1783,0.2663,4.75k,4.98k,7.42M,,7.27M,1.90%,0.00%,2.01k,0.31,0.03%,0.03%,2.13k,,,,,,0.00%,,,1:4,"Nov 23, 1997","Jun 29, 2020","Mar 30, 2021",-7.29%,-7.09%,-7.69%,-43.23%,9.65M,1.30,-1.40%,4.2M,-638.87k,-755.39k,-0.1010,,1.65M,0.22,1.84M,144.34,1.31,0.10,341.94k,534.58k,Value,19087,Healthcare,38,"Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and pachymeter that measures the thickness of cornea. The company also provides color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; distributes intraocular gas products, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and manufactures and distributes a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it offers disposable surgical packs that are used in vitreoretinal surgery; viscous fluid transfer systems and related disposable syringe products, which aid surgeons in the process of injecting and extracting silicone oil; and AXIS Image management system for managing images through the Web browser from various devices regardless of modality, manufacturer, or location. The company sells its products to medical institutions through independent sales representatives, a network of distributors, and internal sales employees. Escalon Medical Corp. was founded in 1987 and is headquartered in Wayne, Pennsylvania.",Wayne,610 688 6830,PA,1609372800,United States,http://www.escalonmedical.com,86400,435 Devon Park Drive,610 688 3641,Medical Devices,Suite 824
